Clinical trial
Randomized Phase II/III Adjuvant Trial Evaluating Feasibility of Standard (A) vs. Customized Treatment (B) in Stage II or Stage IIIA Non-N2, Non-squamous Non Small Cell Lung Cancer (NSCLC).
NCT00775385 is registered in ClinicalTrials.gov with Intergroupe Francophone de Cancerologie Thoracique as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Phase II/III Adjuvant Trial Evaluating Feasibility of Standard (A) vs. Customized Treatment (B) in Stage II or Stage IIIA Non-N2, Non-squamous Non Small Cell Lung Cancer (NSCLC).
- Lead sponsor
- Intergroupe Francophone de Cancerologie Thoracique
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- April 30, 2009
- Completion date
- January 21, 2016
- Enrollment
- 152 (actual)
- Sites
- 42
Conditions
As the registry lists them; a condition with its own page is linked.